Private Capital Advisory
Anyone know about Private Capital Advisory? What do they do and how’s the exposure/exit? A friend’s having an interview soon but have no idea. Any insights appreciated
Anyone know about Private Capital Advisory? What do they do and how’s the exposure/exit? A friend’s having an interview soon but have no idea. Any insights appreciated
| +233 | Downfall of Qatalyst | 45 | 10h |
| +176 | UBS IB 26Q2 a Disaster! Advisory Revenue Down 23%, Capital MarketsDown 5% | 24 | 1h |
| +116 | UBS Americas IB: The Kids’ Table of Wall Street | 15 | 1d |
| +82 | Lincoln International Return Offers | 42 | 2d |
| +58 | London IB BB is a challenge | 36 | 2h |
| +54 | so confused about 28 SA timeline | 27 | 6d |
| +40 | SharePoint makes IB hours HELL | 15 | 1h |
| +39 | momentum of Rx groups | 12 | 10h |
| +37 | Fired during interview | 6 | 1d |
| +34 | VP Lifestyle at Top BB Coverage Groups | 19 | 52m |
Career Resources
Based on previous WSO threads, here's what you need to know about Private Capital/Private Market Advisory:
Role and Function:
Top Firms:
Work Environment:
Exposure and Exit Opportunities:
For more specific insights into JPM's Private Capital Advisory team in London, it would be beneficial to connect with current or former employees or look for more detailed discussions on WSO forums.
Sources: What is Private Capital / Private Market Advisory?, Private Funds Group (CS/UBS etc), Exposure&Exit opportunity JPM structured Equity Financing, How is PJT London?, JP Morgan Exit Opps to Private Equity?
The space is dominated by Evercore>JEF>>> everyone else. JPM isn't bad, but they certainly aren't good.
Think you’re thinking of secondaries? JPM doesn’t have secondaries team, they have some wack partnership with Campbell. This group is something else.
Does PCA mean somthing different in Europe?
Did your friend hear back? I interviewed for the same role but yet to hear anything
Exits are ofc limited to secondaries PE or IR. V little chance at direct investing PE, or corp dev. Worth being aware off these limitations and that exit options are far more narrow vs being in M&A
Question - where are your thoughts on PCA and private funds (primaries) advising? Is the product group thriving, or dying? For private funds, is the product lucrative/growing enough to build an entire career out of, or best when cross-sold with secondaries advisory?
Sint magni mollitia quas qui culpa saepe sit. Consequatur aut dolores delectus esse commodi velit laudantium.
Et corrupti laudantium voluptatibus ad accusantium saepe. Et facere ut et suscipit ea voluptatum. Est laborum odio ut quas sed recusandae dolor. Veniam eveniet sit eaque eaque voluptatum.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...